JPMorgan Chase & Co. Boosts Holdings in Sabra Healthcare REIT, Inc. $SBRA

JPMorgan Chase & Co. lifted its holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 33.7% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,589,253 shares of the real estate investment trust’s stock after purchasing an additional 903,841 shares during the period. JPMorgan Chase & Co.’s holdings in Sabra Healthcare REIT were worth $66,904,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. Covestor Ltd boosted its position in Sabra Healthcare REIT by 23,720.0% in the 3rd quarter. Covestor Ltd now owns 2,382 shares of the real estate investment trust’s stock valued at $45,000 after buying an additional 2,372 shares during the period. EverSource Wealth Advisors LLC raised its stake in shares of Sabra Healthcare REIT by 150.7% in the second quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock valued at $47,000 after acquiring an additional 1,536 shares in the last quarter. Farther Finance Advisors LLC boosted its holdings in Sabra Healthcare REIT by 685.7% in the third quarter. Farther Finance Advisors LLC now owns 3,952 shares of the real estate investment trust’s stock valued at $74,000 after purchasing an additional 3,449 shares during the period. Hantz Financial Services Inc. grew its stake in Sabra Healthcare REIT by 209.1% during the 3rd quarter. Hantz Financial Services Inc. now owns 3,956 shares of the real estate investment trust’s stock worth $74,000 after purchasing an additional 2,676 shares in the last quarter. Finally, Compass Wealth Management LLC acquired a new position in shares of Sabra Healthcare REIT during the third quarter worth about $89,000. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms recently commented on SBRA. Wall Street Zen lowered Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a report on Friday, January 23rd. Truist Financial upped their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “hold” rating in a report on Tuesday, January 20th. Jefferies Financial Group reiterated a “buy” rating and issued a $22.00 price target on shares of Sabra Healthcare REIT in a research note on Monday, December 15th. Citizens Jmp raised their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock a “market outperform” rating in a report on Wednesday, February 18th. Finally, Citigroup upped their target price on shares of Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a “buy” rating in a report on Wednesday, February 18th. Five analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Sabra Healthcare REIT has an average rating of “Moderate Buy” and a consensus price target of $21.70.

Sabra Healthcare REIT Trading Up 0.4%

SBRA opened at $20.51 on Wednesday. The firm has a market cap of $5.17 billion, a price-to-earnings ratio of 32.05, a price-to-earnings-growth ratio of 1.64 and a beta of 0.67. Sabra Healthcare REIT, Inc. has a 52 week low of $15.75 and a 52 week high of $20.70. The business’s 50 day moving average is $19.20 and its two-hundred day moving average is $18.86. The company has a quick ratio of 4.29, a current ratio of 4.29 and a debt-to-equity ratio of 0.90.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings data on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.26). The firm had revenue of $201.35 million during the quarter, compared to analyst estimates of $201.97 million. Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. Sabra Healthcare REIT’s revenue was up 16.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, research analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 27th. Shareholders of record on Friday, February 13th will be paid a $0.30 dividend. The ex-dividend date is Friday, February 13th. This represents a $1.20 dividend on an annualized basis and a yield of 5.9%. Sabra Healthcare REIT’s payout ratio is currently 187.50%.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.